首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1462591

全球勝胜肽合成市場

Peptide Synthesis: Global Markets

出版日期: 2024年04月08日 | 出版商:

BCC Research | 英文 135 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

全球勝胜肽合成市場規模預計將從2023年的901億美元成長到2028年底的1,575億美元，預測期內年複合成長率為11.8%。

全球胜肽合成市場規模預計將從2023年的283億美元成長到2028年底的516億美元，同期年複合成長率為12.8%。全球生物活性勝胜肽市場規模預計將從2023年的183億美元成長到2028年底的330億美元，年複合成長率為12.6%。

本報告調查了全球勝胜肽合成市場，並提供了市場概況、法律制度、市場影響因素和市場機會分析、市場規模趨勢和預測、各個細分市場和地區的詳細分析、競爭格局和主要企業市場機會。

市場區隔：

依勝胜肽類型

勝胜肽合成
胜肽
荷爾蒙勝胜肽
生物活性勝胜肽
膠原蛋白胜肽
其他

按用途

癌症
糖尿病
神經
其他（心臟病、罕見疾病等）
勝胜肽療法
化妝品
營養補充食品
其他（藥物發現、醫學影像診斷）

依成分類型：

固相
溶液相
混合相

分類細目
全球勝胜肽合成市場：按胜肽類型
勝胜肽合成
胜肽
荷爾蒙勝胜肽
生物活性勝胜肽
膠原蛋白胜肽
其他
全球勝胜肽合成市場：依應用分類
勝胜肽療法
化妝品
營養補充食品
其他
全球勝胜肽合成市場：依合成類型
固相
溶液相
混合相
全球勝胜肽合成市場：按地區
北美洲
歐洲
亞太地區
其他地區

第6章競爭狀況

主要企業
戰略分析
併購分析
併購交易
不斷壯大的生物技術新興企業
Neumora Therapeutics Inc.
Altos Labs
Affini-T Therapeutics
Capstan Therapeutics
Septerna Inc.

第7章胜肽合成產業的永續性：ESG 視角

ESG 對於勝胜肽治療藥物製造商的重要性
胜肽治療藥物生產企業的ESG實踐
BCC 的觀點

第8章附錄

調查方法
參考
公司簡介
ABBOTT
ABBVIE INC.
AMGEN INC.
ASTRAZENECA
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
BRISTOL MYERS SQUIBB CO.
B. BRAUN SE
LILLY
MERCK & CO. INC.
MODERNA INC.
NOVARTIS AG
NOVO NORDISK A/S
SANOFI
TEVA PHARMACEUTICAL INDUSTRIES LTD.

簡介目錄圖表

Product Code: BIO252A

The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.

The global market for synthetic peptides is expected to grow from $28.3 billion in 2023 and projected to reach $51.6 billion by the end of 2028, at a compound annual growth rate (CAGR) of 12.8% during the forecast period of 2023 to 2028.

The global market for bioactive peptides is expected to grow from $18.3 billion in 2023 and projected to reach $33.0 billion by the end of 2028, at a compound annual growth rate (CAGR) of 12.6% during the forecast period of 2023 to 2028.

Report Scope

The report provides a detailed summary of the peptide synthesis market, with a focus on peptide therapeutics; a competitive landscape; and company profiles that include revenue, product portfolio and news in development. The report analyzes market trends and dynamics, including drivers, restraints and opportunities. This research study discusses historical year, base year and potential market size for the forecast period.

The report will enable key players, other strategists and start-ups to make informed decisions about the production, marketing and licensing of goods and services. Organizations, exporters and distributors should find the information about market development and trends useful. The segments of the market provided in the report are peptide type, applications and synthesis type. Regional market analysis is provided for all segments, and country-level analysis in some cases. Key developments and ESG information for the companies is provided based on the market.

The market is divided into segments and by application/industry as follows:

By peptide types:

Synthetic peptides.
Antimicrobial peptides.
Hormonal peptides.
Bioactive peptides.
Collagen peptides.
Others.

By application:

Cancer.
Diabetes.
Neurology.
Others (cardiology, rare diseases, etc.).
Peptide therapeutics.
Cosmetics.
Nutraceuticals.
Others (drug discovery, medical imaging).

By synthesis type:

Solid-phase.
Solution-phase.
Hybrid-phase.

For each of these areas, current products in the market are identified, measuring the market size and identifying potential market drivers. Forecasts for 2028 are attained by analyzing the current competitors' market shares for the base year of 2022. A top-down approach was also followed to determine peptide synthesis market shares in 2022 by consulting secondary and primary sources.

By geographic region, the market is segmented into North America, Europe, Asia-Pacific and the Rest of World. The markets in countries such as the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico and GCC countries are analyzed. For market estimates, data is provided for 2022 as the base year, with estimates for 2023 and forecast values for 2028.

Report Includes

63 data tables and 56 additional tables
An overview of the global market for peptide synthesis
Analyses of the global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
Estimate of the actual market size and revenue forecast, and a corresponding market share analysis by product type, synthesis area, application, end-user, and region
Facts and figures pertaining to major market dynamics, technological trends, latest developments in peptide production, pipeline drugs (manufactured using peptides), and future prospects
Discussion of sustainability trends and factors, with emphasis on consumer attitudes, companies' ESG scores, the future of ESG, case studies and the ESG practices of companies
Overview of the major vendors along with an analysis of the industry structure, including company market shares, recent M&A activity and venture funding outlook
Competitive intelligence on the leading market players, including their product developments, business strategies, key financials and segmental revenues
Profiles of the leading global players, including Novo Nordisk A/S., AbbVie Inc., Lilly, Novartis Ag, AstraZeneca, and Teva Pharmaceutical

Chapter 1 Executive Summary

Market Outlook
Scope of Report
Market Summary

Chapter 2 Market Overview

Peptide Therapeutics
Importance of Peptides
Peptide Synthesis
Trends in Peptide Therapeutics

Chapter 3 Market Dynamics

Market Drivers
Overview
Rising Incidence of Chronic Diseases
Developments in Peptide Drug Delivery
Increase in Biotech Spending
Increase in Infectious and Chronic Diseases
Market Restraints
Issues in Sustainability in Synthetic Peptide Production
Market Opportunities
Oral Peptide Therapeutics
Opportunities in Emerging Nations

Chapter 4 Emerging Technologies for Peptide Synthesis and Therapeutics Manufacturing

Introduction
Advances in SPPS in Aqueous Media
Chemical Synthesis
Peptide Drug Delivery
Examples of New Developments, by Company
Nissan Chemical Corp.
Gyros Protein Technologies AB

Chapter 5 Market Analysis, by Segment

Segmentation Breakdown
Peptide Synthesis by Peptide Type
Global Market for Peptide Synthesis, by Peptide Type
Synthetic Peptides
Antimicrobial Peptides
Hormonal Peptides
Bioactive Peptides
Collagen Peptides
Other Products
Global Market for Peptide Synthesis, by Application
Peptide Therapeutics
Cosmetics
Nutraceuticals
Other Types of Applications
Peptide Synthesis by Synthesis Type
Global Market for Peptide Synthesis by Synthesis Type
Solid-phase
Solution-phase
Hybrid-phase
Peptide Synthesis by Region
Regional Breakdown
Global Market for Peptide Synthesis, by Region
North America
Europe
Asia-Pacific
Rest of the World

Chapter 6 Competitive Landscape

Top Players
Strategic Analysis
M&A Analysis
M&A Deals in 2020-2023
Flourishing Biotech Startups (2023)
Neumora Therapeutics Inc.
Altos Labs
Affini-T Therapeutics
Capstan Therapeutics
Septerna Inc.

Chapter 7 Sustainability in the Peptide Synthesis Industry: An ESG Perspective

Importance of ESG among Peptide Therapeutics Manufacturers
ESG Practices of Peptide Therapeutics Manufacturers
BCC Research Viewpoint

Chapter 8 Appendix

Research Methodology
References
Company Profiles
ABBOTT
ABBVIE INC.
AMGEN INC.
ASTRAZENECA
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
BRISTOL MYERS SQUIBB CO.
B. BRAUN SE
LILLY
MERCK & CO. INC.
MODERNA INC.
NOVARTIS AG
NOVO NORDISK A/S
SANOFI
TEVA PHARMACEUTICAL INDUSTRIES LTD.

簡介目錄圖表

List of Tables

Summary Table : Global Market for Peptide Synthesis, by Peptide Type, Through 2028
Table 1 : Pros and Cons of Liquid Phase and Solid Phase Synthesis
Table 2 : Global Cancer Incidence
Table 3 : Emerging Trends in Peptide Synthesis Technologies
Table 4 : Global Market for Peptide Synthesis, by Peptide Type, Through 2028
Table 5 : Global Market for Synthetic Type Peptides, by Region, Through 2028
Table 6 : Global Market for Antimicrobial Type Peptides, by Region, Through 2028
Table 7 : FDA-Approved Antimicrobial Peptide Drugs
Table 8 : Global Market for Hormonal Peptides, by Region, Through 2028
Table 9 : Global Market for Bioactive Peptides, by Region, Through 2028
Table 10 : Global Market for Collagen Peptides, by Region, Through 2028
Table 11 : Global Market for Other Peptides, by Region, Through 2028
Table 12 : Global Market for Peptide Synthesis, by Application, Through 2028
Table 13 : Global Market for Peptide Therapeutics, by Region, Through 2028
Table 14 : Peptide-based Drugs Approved by FDA in 2021
Table 15 : Best-Selling Peptide Therapeutics, 1982-2021
Table 16 : Global Market for Cancer Applications in Peptide Therapeutics, by Region, Through 2028
Table 17 : Approval of Peptide Agents Used for Cancer Therapy, 2019-2022
Table 18 : Global Market for Diabetes Applications in Peptide Therapeutics, by Region, Through 2028
Table 19 : Global Market for Neurology Applications in Peptide Therapeutics, by Region, Through 2028
Table 20 : Global Market for Other Applications in Peptide Therapeutics, by Region, Through 2028
Table 21 : Global Market for Cosmetics Applications in Peptide Synthesis, by Region, Through 2028
Table 22 : Global Market for Nutraceutical Applications in Peptide Synthesis, by Region, Through 2028
Table 23 : Global Market for Other Applications in Peptide Synthesis, by Region, Through 2028
Table 24 : Global Market for Peptide Synthesis, by Synthesis Type, Through 2028
Table 25 : Global Market for Solid-phase Synthesis, by Region, Through 2028
Table 26 : Global Market for Solution-phase Synthesis, by Region, Through 2028
Table 27 : Global Market for Hybrid-phase Synthesis, by Region, Through 2028
Table 28 : Global Market for Peptide Synthesis, by Region, Through 2028
Table 29 : North American Market for Peptide Synthesis, by Country, Through 2028
Table 30 : Protein Subunit Vaccines, in Clinical Phases, 2021-2022
Table 31 : European Market for Peptide Synthesis, by Country, Through 2028
Table 32 : Products and Services in Nordic Countries, 2020-2023
Table 33 : Asia-Pacific Market for Peptide Synthesis, by Country, Through 2028
Table 34 : Japanese Market Statistics
Table 35 : RoW Market for Peptide Synthesis, by Country, Through 2028
Table 36 : Role of ESG in Environmental Performance
Table 37 : Role of ESG in Social Performance
Table 38 : Role of ESG in Governance Performance
Table 39 : ESG Rankings for Major Peptide Therapeutics Companies*
Table 40 : Abbott: Company Snapshot
Table 41 : Abbott: Financial Performance, FY 2022 and 2023
Table 42 : Abbott: Product Portfolio
Table 43 : Abbott: Recent Developments, 2022
Table 44 : AbbVie Inc.: Company Snapshot
Table 45 : AbbVie Inc.: Financial Performance, FY 2022 and 2023
Table 46 : AbbVie Inc.: Product Portfolio
Table 47 : AbbVie Inc.: Recent Developments, 2022
Table 48 : Amgen Inc.: Company Snapshot
Table 49 : Amgen Inc.: Financial Performance, FY 2022 and 2023
Table 50 : Amgen Inc.: Product Portfolio
Table 51 : Amgen Inc.: Recent Developments, 2023
Table 52 : AstraZeneca: Company Snapshot
Table 53 : AstraZeneca: Financial Performance, FY 2022 and 2023
Table 54 : AstraZeneca: Product Portfolio
Table 55 : AstraZeneca: Recent Developments, 2024
Table 56 : Boehringer Ingelheim International GmbH: Company Snapshot
Table 57 : Boehringer Ingelheim International: Financial Performance, FY 2021 and 2022
Table 58 : Boehringer Ingelheim International: Product Portfolio
Table 59 : Boehringer Ingelheim International: Recent Developments, 2023
Table 60 : Bristol Myers Squibb Co.: Company Snapshot
Table 61 : Bristol Myers Squibb Co.: Financial Performance, FY 2022 and 2023
Table 62 : Bristol Myers Squibb Co.: Product Portfolio
Table 63 : Bristol Myers Squibb Co.: Recent Developments, 2022
Table 64 : B. Braun SE: Company Snapshot
Table 65 : B. Braun SE: Financial Performance, FY 2021 and 2022
Table 66 : B. Braun SE: Product Portfolio
Table 67 : B. Braun SE: Recent Developments, 2022
Table 68 : Lilly: Company Snapshot
Table 69 : Lilly: Financial Performance, FY 2022 and 2023
Table 70 : Lilly: Product Portfolio
Table 71 : Lilly: Recent Developments, 2022
Table 72 : Merck & Co. Inc.: Company Snapshot
Table 73 : Merck & Co. Inc.: Financial Performance, FY 2022 and 2023
Table 74 : Merck & Co. Inc.: Product Portfolio
Table 75 : Merck & Co. Inc.: Recent Developments, 2021
Table 76 : Moderna Inc.: Company Snapshot
Table 77 : Moderna Inc.: Financial Performance, FY 2022 and 2023
Table 78 : Moderna Inc.: Product Portfolio
Table 79 : Moderna Inc.: Recent Developments, 2022
Table 80 : Novartis AG: Company Snapshot
Table 81 : Novartis AG: Financial Performance, FY 2022 and 2023
Table 82 : Novartis AG: Product Portfolio
Table 83 : Novartis AG: Recent Developments, 2023
Table 84 : Novo Nordisk A/S: Company Snapshot
Table 85 : Novo Nordisk A/S: Financial Performance, FY 2022 and 2023
Table 86 : Novo Nordisk A/S: Product Portfolio
Table 87 : Novo Nordisk A/S: Recent Developments, 2024
Table 88 : Sanofi: Company Snapshot
Table 89 : Sanofi: Financial Performance, FY 2022 and 2023
Table 90 : Sanofi: Product Portfolio
Table 91 : Sanofi: Recent Developments, 2022
Table 92 : Teva Pharmaceutical Industries Ltd.: Company Snapshot
Table 93 : Teva Pharmaceutical: Financial Performance, FY 2022 and 2023
Table 94 : Teva Pharmaceutical: Product Portfolio
Table 95 : Teva Pharmaceutical: Recent Developments, 2024

List of Figures

Summary Figure : Global Market Shares of Peptide Synthesis, by Peptide Type, 2022
Figure 1 : Trends in Peptide Therapeutics Manufacturing
Figure 2 : Global Market for Peptide Synthesis: Market Dynamics
Figure 3 : India's Biotechnology Sectoral Thrust
Figure 4 : Global Projected Incidence of Diabetes, Patients Age 20-79, 2010 and 2030
Figure 5 : Global Infectious Disease Outbreaks, 2020 to 2022
Figure 6 : Global Infectious Disease Outbreak, 2022
Figure 7 : Snapshot: Key Trends in Peptide Drugs and Therapeutics Technologies
Figure 8 : Global Market Shares of Peptide Synthesis, by Peptide Type, 2022
Figure 9 : Global Market Shares of Peptide Synthesis, by Application, 2022
Figure 10 : Global Market Shares of Peptide Synthesis, by Synthesis Type, 2022
Figure 11 : Global Market Shares of Peptide Synthesis, by Region, 2022
Figure 12 : North American Market Shares of Peptide Synthesis, by Application, 2022
Figure 13 : North American Market Shares of Peptide Therapeutics in Peptide Synthesis, by Application, 2022
Figure 14 : North American Market Shares of Peptide Synthesis, by Peptide Type, 2022
Figure 15 : North American Market Shares of Peptide Synthesis, by Synthesis Type, 2022
Figure 16 : North American Market Shares of Peptide Synthesis, by Country, 2022
Figure 17 : European Market Shares of Peptide Synthesis, by Application, 2022
Figure 18 : European Market Shares of Peptide Therapeutics in Peptide Synthesis, by Application, 2022
Figure 19 : European Market Shares of Peptide Synthesis, by Peptide Type, 2022
Figure 20 : European Market Shares of Peptide Synthesis, by Synthesis Type, 2022
Figure 21 : European Market Shares of Peptide Synthesis, by Country, 2022
Figure 22 : Asia-Pacific Market Shares of Peptide Synthesis, by Application, 2022
Figure 23 : Asia-Pacific Market Shares of Peptide Therapeutics in Peptide Synthesis, by Application, 2022
Figure 24 : Asia-Pacific Market Shares of Peptide Synthesis, by Peptide Types, 2022
Figure 25 : Asia-Pacific Market Shares of Peptide Synthesis, by Synthesis Type, 2022
Figure 26 : Asia-Pacific Market Shares of Peptide Synthesis, by Country, 2022
Figure 27 : RoW Market Shares of Peptide Synthesis, by Application, 2022
Figure 28 : RoW Market Shares of Peptide Therapeutics in Peptide Synthesis, by Application, 2022
Figure 29 : RoW Market Shares of Peptide Synthesis, by Peptide Types, 2022
Figure 30 : RoW Market Shares of Peptide Synthesis, by Synthesis Type, 2022
Figure 31 : RoW Market Shares of Peptide Synthesis, by Country/Region, 2022
Figure 32 : Leading Manufacturers' Shares of the Global Market for Peptide Synthesis, 2022
Figure 33 : Snapshot: Key ESG Trends in Peptide Therapeutics Industry
Figure 34 : Abbott: Revenue Shares, by Business Unit, FY 2023
Figure 35 : Abbott: Revenue Shares, by Country/Region, FY 2023
Figure 36 : AbbVie Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 37 : AbbVie Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 38 : Amgen Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 39 : Amgen Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 40 : AstraZeneca: Revenue Shares, by Business Unit, FY 2023
Figure 41 : AstraZeneca: Revenue Shares, by Country/Region, FY 2023
Figure 42 : Boehringer Ingelheim International: Revenue Shares, by Business Unit, FY 2022
Figure 43 : Boehringer Ingelheim International: Revenue Shares, by Country/Region, FY 2022
Figure 44 : Bristol Myers Squibb Co.: Revenue Shares, by Business Unit, FY 2023
Figure 45 : Bristol Myers Squibb Co.: Revenue Shares, by Country/Region, FY 2023
Figure 46 : B. Braun SE: Revenue Shares, by Business Unit, FY 2022
Figure 47 : B. Braun SE: Revenue Shares, by Country/Region, FY 2022
Figure 48 : Lilly: Revenue Shares, by Business Unit, FY 2023
Figure 49 : Lilly: Revenue Shares, by Country/Region, FY 2023
Figure 50 : Merck & Co. Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 51 : Merck & Co. Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 52 : Moderna Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 53 : Novartis AG: Revenue Shares, by Business Unit, FY 2023
Figure 54 : Novartis AG: Revenue Shares, by Country/Region, FY 2023
Figure 55 : Novo Nordisk A/S: Revenue Shares, by Business Unit, FY 2023
Figure 56 : Novo Nordisk A/S: Revenue Shares, by Country/Region, FY 2023
Figure 57 : Sanofi: Revenue Shares, by Business Unit, FY 2023
Figure 58 : Sanofi: Revenue Shares, by Country/Region, 2023
Figure 59 : Teva Pharmaceutical: Revenue Shares by Business Unit, FY 2023
Figure 60 : Teva Pharmaceutical: Revenue Shares, by Country/Region, FY 2023